Replies to post #2342 on RespireRx Pharmaceuticals Inc (RSPI)

[bladerunner1717]

gfp,

Do you really believe that Organon would have put another Amkapine into clinicals, if they believed that the problem seen with CX717 was a classs-wide effect?


Bladerunner